Cellular, molecular and systems-level mechanisms of aging.
Age-related disease: what drives it and what slows it.
Measuring biological age, inflammation, metabolic health and fitness.
The institutes and companies building the future of longevity.
Evidence on NMN, rapamycin, metformin, spermidine and other longevity molecules.
Caloric restriction, TRE, fasting-mimicking diets and longevity-friendly eating.
Zone 2, VO2 max, strength training and the movement stack for healthspan.
Sleep architecture, circadian rhythm, stress and recovery protocols.
Senolytics, gene and stem cell therapy, peptides, plasma exchange and HBOT.
New findings from peer-reviewed longevity and aging research.
Human trials in longevity interventions, supplements and drugs.
Companies, funding rounds and business news in the longevity space.
Big pharma moves, biotech launches and drug development.
AI and machine learning applied to aging, diagnosis and drug discovery.
FDA, EMA and policy developments affecting longevity medicine.
ARDD, Longevity Summit, Foresight and other events.
Tests, devices, supplements and tools shipping to consumers.
Profiles of researchers, physicians and thinkers shaping the field.
Long-form opinion, editorials and perspective pieces.
From strong human trials to mouse-only data.
An evidence-based look at How we grade supplement evidence as part of our Browse by Evidence guide in Supplements Database. What the human research actually shows, the strongest mechanistic case, and what it means for healthspan.
One short email a week. Papers we read, claims we graded, interventions that actually have human data. No hype. No pseudoscience. Just what the data shows.
Free. Unsubscribe any time. We will never share your email.